FDA Warns of Dangers of Compounded Ketamine for Psychiatric Use
HealthDay News — The U.S. Food and Drug Administration is warning consumers about risks of using compounded versions of the drug...
top of page
Child Psychiatrist /Adult Psychiatrist
Blog
Search
chrisviesumalinog
- Nov 7
- 4 min
Early Sleep Improvement and Response to Pharmacotherapy in Psychotic Depression
Does early improvement in insomnia predict response to pharmacotherapy in psychotic depression? Authors performed a secondary analysis of...
00
chrisviesumalinog
- Nov 7
- 4 min
Orexin: The New Kid on the Insomnia Block
The newest class of medications to treat insomnia have many advantages. CONFERENCE REPORTER Dual orexin receptor antagonists (DORAs), the...
00
chrisviesumalinog
- Nov 7
- 5 min
Appropriate Use of Stimulant Medications in Adults With ADHD
Over the past 2 decades, the attention-deficit/hyperactivity disorder (ADHD) treatment spectrum has expanded to include...
00
chrisviesumalinog
- Nov 7
- 3 min
Lag in Antidepressant Treatment Response Explained?
Antidepressant ARCELONA — The typical lag between treatment initiation with selective serotonin reuptake inhibitors (SSRIs) for...
00
chrisviesumalinog
- Nov 7
- 4 min
GLP-1 Agonists and Suicide Risk: What Action Should Be Taken?
GLP-1 Agonists and Suicide Risk A statement from the European Medicines Agency (EMA) about semaglutide and, more generally, glucagon-like...
00
chrisviesumalinog
- Nov 7
- 4 min
Esketamine Bests Quetiapine for Severe Depression in Head-to-Head Trial
Esketamine Bests Quetiapine for Severe Depression in Head-to-Head Trial BARCELONA — Intranasal esketamine (Spravato, Janssen) is superior...
00
chrisviesumalinog
- Nov 7
- 2 min
Ketamine No Better for Depression Than Placebo?
Ketamine TOPLINE: Ketamine was no more effective than placebo in reducing depressive symptoms in surgical patients with major depressive...
00
chrisviesumalinog
- Nov 7
- 1 min
FDA Clears First OTC Fentanyl Urine Test
The US Food and Drug Administration (FDA) has cleared the first over-the-counter test for the preliminary detection of fentanyl in urine....
00
Vilash Reddy, MD
- Nov 3
- 1 min
Looking for a Psychiatrist that takes your Insurance?
It can be challenging, frustrating trying to find a psychiatrist that takes your insurance as more psychiatrist are opting out of...
100
chrisviesumalinog
- Oct 16
- 4 min
Cannabis Commercialization Linked to More Hospitalizations
The commercialization of cannabis that followed its legalization for nonmedical use was associated with an increase in hospitalizations...
10
chrisviesumalinog
- Oct 16
- 4 min
Confirmed: Intermittent Use of Benzodiazepines Is the Safest Option
Intermittent Use of Benzodiazepines BARCELONA — Intermittent benzodiazepine use significantly reduces the risk for falls, fractures, and...
20
chrisviesumalinog
- Oct 9
- 2 min
Study Finds Esketamine Nasal Spray More Likely to Induce Remission in Treatment-Resistant MDD Than Q
“Over 32 weeks of follow-up, the percentage of patients with remission, the percentage of patients with a treatment response, and the...
40
chrisviesumalinog
- Oct 7
- 5 min
The Making of Adult ADHD: The Rapid Rise of a Novel Psychiatric Diagnosis
"The history of psychiatry is a history of fads in theory, diagnosis, and treatment. Such rapid shifts in conceptualization—such as the...
40
chrisviesumalinog
- Oct 7
- 4 min
Providing Hope During National Suicide Prevention Month
National Suicide Prevention Month is upon us again. This month represents hope: hope as we create more awareness around suicide; hope...
10
chrisviesumalinog
- Oct 2
- 1 min
Fentanyl Laced Stimulants Fuel Opioid Crisis' Fourth Wave
The overdose crisis in the US has seen a significant increase in drug overdose deaths, with fentanyl-laced stimulants fueling the fourth...
10
chrisviesumalinog
- Oct 2
- 1 min
Gabapentin May Not Reduce Opioid Use in Chronic Opioid Users
A retrospective cohort study published in Regional Anesthesia and Pain Medicine found that off-label gabapentin prescriptions did not...
10
chrisviesumalinog
- Oct 2
- 1 min
FDA Approves First Oral Selective 5HT1A Receptor Agonist for MDD
The US Food and Drug Administration (FDA) has approved Gepirone hydrochloride extended-release tablets (Exxua) as the first oral...
10
chrisviesumalinog
- Oct 2
- 2 min
“Talk. They Hear You.” Celebrates 10 Years of Preventing Underage Substance Use
"Talk. They Hear You."® is a national prevention campaign by SAMHSA that aims to increase parents' awareness of underage substance use...
00
chrisviesumalinog
- Oct 1
- 2 min
Study Says Casual Pot Use Harmful to Teens
A new study published in the Journal of the American Medical Association (JAMA) found that recreational marijuana use among teenagers is...
20
bottom of page